FDA’s plan to propose ban on formaldehyde in hair-straightening products remains in limbo under Trump administration
A plan for the US Food and Drug Administration to propose banning formaldehyde and certain formaldehyde-releasing chemicals ...
Rolling Out1h
FDA recalls millions of Dunkin’ treats over safety alert
FDA announces recall affecting millions of Dunkin' baked goods including beloved Munchkins, donuts, and fritters - here's ...
Hosted on MSN2h
Biohaven Just Hurdled An FDA Setback — And Its Moving Lines
Biohaven stock hurdled its 50-day and 200-day lines Tuesday after the FDA granted its SCA treatment a speedier review time.
STAT3d
Experts fear disruptions at FDA as Trump offers buyouts and layoff reports swirl
The Trump administration’s overarching message to the legions of people powering the federal government is simple: Leave.
Over 89,000 Bottles of Nasal Spray Recalled By FDA—What to Know
There’s another recall to be aware of right now, and it involves nose spray. NeilMed Pharmaceuticals Inc., the manufacturer of NasoGel Spray, has issued an international recall of 89,312 of its sprays ...
Hosted on MSN21m
Travere Therapeutics Skyrockets After Reaching FDA Deal For Kidney Disease Drug
Travere Therapeutics reached an agreement Tuesday on what data the FDA would require to approve its drug for a kidney disease.
FDA to propose ban on chemical used in certain hair products, to preserve dead bodies
The future of formaldehyde in hair straighteners remains uncertain as the FDA has proposed a ban on the chemical, which is commonly used in these products. Formaldehyde is a known carcinogen, raising ...
Convenience Store News22h
Will Trump Administration Result in a New Approach to Tobacco and Nicotine Regulation?
Only time will tell what is next in the landscape of tobacco and nicotine regulation from the White House and the FDA.
medtechdive2h
Former FDA head Gottlieb calls for less regulation of certain AI tools
Gottlieb, who led the agency during the first Trump presidency, supports a reversion to an earlier interpretation of the 21st Century Cures Act.
Biohaven Announces FDA Acceptance and Priority Review of Troriluzole New Drug Application for the Treatment of Spinocerebellar Ataxia
Biohaven Ltd. (NYSE: BHVN) (Biohaven or the Company), today announced that the US Food and Drug Administration (FDA) has ...
Health groups sound alarm on missing CDC, FDA data
Prominent health care organizations urge the Trump administration to restore important data sets on the Centers for Disease ...
Travere to Seek FDA OK of Filspari in Rare Kidney Disorder FSGS; Shares Rally
Travere Therapeutics shares rose sharply in early trading Tuesday after the biopharmaceutical company said it plans to seek expanded Food and Drug Administration approval of its kidney-disease drug ...